Doxorubicin-Based Chemotherapy for the Palliative Treatment of Adult Patients with Locally Advanced or Metastatic Soft-Tissue Sarcoma: A Meta-Analysis and Clinical Practice Guideline

This publication has 26 references indexed in Scilit:

• Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
  Journal of Clinical Oncology, 1999
• High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
  British Journal of Cancer, 1998
• Chemotherapy for metastatic soft tissue sarcomas – another full circle?
  British Journal of Cancer, 1991
• High-dose DTIC in advanced soft-tissue sarcomas in the adult
  Annals of Oncology, 1991
• Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas
  Cancer, 1990
• Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
  Journal of Clinical Oncology, 1989
• Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group
  European Journal of Cancer and Clinical Oncology, 1987
• Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
  Journal of Clinical Oncology, 1987
• Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
  European Journal of Cancer and Clinical Oncology, 1987
• Chemotherapy of advanced soft-tissue sarcomas in adults
  Cancer Treatment Reviews, 1977